Choose any two compounds below to see them side by side. Each comparison page lines up the level of evidence behind each one, the registered clinical trials, and where each stands with regulators, so the differences are easy to see in one place.
Popular comparisons
- Cagrilintide vs Berobenatide
- UBT251 vs Berobenatide
- Retatrutide vs Berobenatide
- Survodutide vs UBT251
- Eloralintide vs Berobenatide
- Retatrutide vs UBT251
- Petrelintide vs Berobenatide
- Semaglutide vs Berobenatide
- Orforglipron vs Berobenatide
- Tirzepatide vs Berobenatide
- Brenipatide vs UBT251
- Cagrilintide vs Brenipatide
- Survodutide vs Brenipatide
- Cagrilintide vs AOD-9604
- Survodutide vs AOD-9604
- AOD-9604 vs UBT251
- Survodutide vs LY4086940
- Nisotirostide vs UBT251
- Petrelintide vs UBT251
- Cagrilintide vs ATX-304
- Survodutide vs ATX-304
- ATX-304 vs UBT251
- Semaglutide vs UBT251
- Amycretin vs UBT251
- Cagrilintide vs Amycretin
- Survodutide vs Amycretin
- Cagrilintide vs Adipotide
- Survodutide vs Adipotide
- Adipotide vs UBT251
- Cagrilintide vs Tradipitant (NEREUS, VLY-686)
- Cagrilintide vs Aleniglipron (GSBR-1290)
- Survodutide vs Aleniglipron (GSBR-1290)
- UBT251 vs Aleniglipron (GSBR-1290)
- Tirzepatide vs UBT251
- Mazdutide vs UBT251
- NBIP-1968 vs UBT251
- Cagrilintide vs BAM15
- Survodutide vs BAM15
- BAM15 vs UBT251
- Cagrilintide vs 5-Amino-1MQ
Most requested comparisons
These are the pairings readers look for most often. Each opens a full side-by-side page.
Weight management compounds
- Retatrutide vs Tirzepatide
- Semaglutide vs Tirzepatide
- Retatrutide vs Semaglutide
- Retatrutide vs Survodutide
- Cagrilintide vs Semaglutide
- Orforglipron vs Semaglutide
- Mazdutide vs Tirzepatide
- Cagrilintide vs Eloralintide
- LY4086940 vs Retatrutide
- LY4086940 vs Orforglipron
Growth hormone related peptides
- Ipamorelin vs Sermorelin
- Sermorelin vs Tesamorelin
- CJC-1295 (no DAC) vs Ipamorelin
- CJC-1295 with DAC vs Ipamorelin
Repair and recovery
Longevity, mitochondria and brain
How to read a comparison
A side-by-side table can make two compounds look equally proven when they are not. Keep these points in mind as you read.
- Evidence level matters more than the headline. Every compound is placed on the same six-tier scale, from published human clinical trials down to community reports. A compound with large human trials and one with only animal studies are not comparable, even when both appear in the same table.
- Registered trials show what is being tested. A trial listed on ClinicalTrials.gov tells you a question is being studied, not that the answer is known. Check the status and phase. You can browse every tracked study on the clinical trial tracker and see recent registry updates in the trial changes feed.
- Regulatory status is specific to a formulation and a country. Approval of one product does not mean every version of that compound is approved.
- Different populations and doses limit direct comparison. Results from separate trials, run in different people over different periods, cannot be lined up as if they came from a head-to-head study unless a comparison page says a head-to-head study exists.
Frequently asked questions
Which compound is better?
These pages do not rank compounds or tell anyone what to use. They show what the published and registered evidence says about each one so you can see where the evidence is strong and where it is thin.
Why are some comparisons mostly empty on one side?
Many popular peptides have little or no human trial data. When that is the case, the comparison says so plainly rather than filling the gap with community claims.
Can I compare doses here?
Reported amounts are documented on each individual peptide page, with the source and evidence tier for every figure. If you need to work out concentrations, the reconstitution calculator is a math tool only and does not suggest an amount.
Where can I see every compound?
The full peptide library lists every entry,.
PeptideBlog is an educational reference compiled from public sources. It is not medical advice, and nothing here is a recommendation for or against any compound.